Hemoglobin level variability: associations with mortality. - Wikidata - awgldk - TriplyDB

Hemoglobin level variability: associations with mortality.

Hemoglobin level variability: associations with mortality.

http://www.wikidata.org/entity/Q36666967

about

Clinical management of nondialysis patients with chronic kidney disease: a retrospective observational study. Data from the SONDA study (Survey Of Non-Dialysis outpAtients)The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit.Pharmacotherapy of end-stage renal disease.Route of epoetin administration influences hemoglobin variability in hemodialysis patients.Determining optimum hemoglobin sampling for anemia management from every-treatment data.Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study.Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients Hemoglobin variability does not predict mortality in European hemodialysis patients.Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM study The effect of altitude change on anemia treatment response in hemodialysis patients Does erythropoietin cause hemoglobin variability--is it 'normal'?Approach to Anemia in Hospitalized Patients with Infectious Diseases; Is it Appropriate?Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients.A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution.Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis.The effect of altitude on dosing and response to erythropoietin in ESRD Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.CERA: third-generation erythropoiesis-stimulating agent.Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease Effective achievement of hemoglobin stability with once-monthly C.E.R.A. in peritoneal dialysis patients: a prospective study.Gastrointestinal bleeding in patients on long-term dialysis Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality.Use of agents stimulating erythropoiesis in digestive diseases Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.Erythropoietic stimulating agents.Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.Individualizing anaemia therapy Four-year stability of anthropometric and cardio-metabolic parameters in a prospective cohort of older adults.Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients.A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.Pre-emptive replacement of water treatment components improves responsiveness to erythropoiesis-stimulating agents in maintenance haemodialysis patients: a quality improvement report.Determinants of hemoglobin variability in stable peritoneal dialysis patients.The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.

P2860

Q30611154-FAE30EE5-DD13-466D-A140-06CA2FBBB2CD Q33412890-8EC81D39-CDE7-4282-BD36-ECF2FFF8DE26 Q33512133-A2501DCC-3561-4594-9C9F-5EC2FC57D7B8 Q33531889-F3436375-51D0-4A78-A6E9-F9AE360FDE03 Q33637889-3FA5AFAE-6ADB-4BF4-8DE7-D1D0EB632328 Q33645279-1392DE51-361C-4837-B505-59E15F285E9D Q33770044-3D799F6C-7066-451A-8AA1-DB5800668AEA Q33817280-6F1D8FE9-B153-43D1-8229-D91B9E948521 Q34281518-E59770AC-C42A-44D3-AD02-3CBB6D829C80 Q34455408-83D8390F-2FAD-494D-88C7-EBA5FC994B56 Q34577650-A8DE16A7-0253-4070-821E-686F372F6B06 Q35017465-320A7C49-4996-48E4-940F-67C2470154E0 Q35141653-02D895D4-14D3-4F59-ADF5-F27593B5EEDA Q35483964-205AFA9C-1D11-42E3-BCF0-286E1E9876FC Q35987846-EE3BF3A5-D0B3-4992-9136-1A749610C3E5 Q36410648-E53A8865-96F2-492D-8E44-82A3509E3661 Q36475617-F152C797-1EC1-41A8-8811-034382630CE2 Q36736806-CDC76F1D-6C8D-4DAC-9958-1158EEBC68A0 Q36947378-8520D539-6204-4681-9C95-DA1418B6E1F3 Q37111869-8A836323-FBD7-44BD-9928-155815015BB7 Q37123128-B6AAFF8D-2D9B-4345-95A5-F29BC156477A Q37123211-4DF7A2C2-498B-4E33-B80C-FEABD6A944FE Q37177208-37E77303-C158-4B8B-8515-C88022B48278 Q37178928-808D0ED0-BB00-4051-B61A-737CFA568706 Q37214510-78C23DD1-4DF7-4F39-B9FB-2DB951DD69C2 Q37258883-C54594BC-4504-420F-9D88-1FE76ACCB8ED Q37368733-9EB84B4F-92F5-4E95-8424-C82499EFF169 Q37487463-4FFB2C2A-4095-40C2-B0E4-5853A208C4CC Q37492328-4BB86F41-342D-45F8-BD23-CFF2453CAB92 Q37693160-803A5CAC-A6AE-4DE1-8604-640FA7871D8B Q38634832-9689C1B2-2C8E-42EC-94C1-9F6A970DBE96 Q40329273-0AC45465-C772-47E6-A9CA-3E9371DFB8DF Q41415087-D0A70678-3202-429A-BC68-6FC9580609E6 Q42276525-A209B089-8B78-428E-B051-D74D61F46610 Q44460872-26F103E7-95C6-4D74-80D3-349287933BEC Q44463941-05DD2A6E-F833-4837-BBBA-E0B2514929BD Q44925626-CF86A42D-0BED-4B2A-B8ED-977A1ED76D28 Q45035169-A9604902-E9D2-4C76-A28B-0F0A3C143481 Q46035828-2B992A85-DF57-4F2B-8C8C-21BFF3AB4528 Q46049718-1A4F3252-BEDC-4454-99B9-DBC063864957

P2860

Hemoglobin level variability: associations with mortality.

http://www.wikidata.org/entity/Q36666967

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Hemoglobin level variability: associations with mortality.

@ast

Hemoglobin level variability: associations with mortality.

@en

type

label

Hemoglobin level variability: associations with mortality.

@ast

Hemoglobin level variability: associations with mortality.

@en

prefLabel

Hemoglobin level variability: associations with mortality.

@ast

Hemoglobin level variability: associations with mortality.

@en

P1433

Q36666967-9EB992D1-E287-4C83-90CF-CDA50ED96DD2

P1476

Q36666967-4082431F-2AFD-4CE9-8F2A-5415BC5CA6BF

P2093

Q36666967-12603681-7EAD-4786-B80C-8E930652A3B7

Q36666967-47116F8C-D50F-45AD-B951-CE341F83A1AF

Q36666967-55ACC9C1-DDC3-4668-B824-F169DE25E355

Q36666967-B750B835-E416-4D3F-96C3-6336FBC3118D

Q36666967-D08B6946-F083-44BF-9B05-9F30F2569CF8

Q36666967-D11E85D6-6F39-4067-B226-32718BFFBD98

P2860

Q36666967-0C939CD8-D56E-4033-9648-48CBFB95073D

Q36666967-B06588EC-9332-4FC2-8FC1-63315E71220E

Q36666967-BA0D7E81-AA36-4887-AAA6-AD657063A7F1

Q36666967-C29192B0-120B-40AB-93A8-E14479838CEE

Q36666967-E21A58FD-405D-4CA9-BF4F-B2338B4ED01D

Q36666967-F849A4EA-5CDD-4078-9E25-54909CB2FBBF

P304

Q36666967-54D2BFCB-ED5D-4BD3-A857-755345261E6C

P31

Q36666967-2AA86AE0-4D63-4A8B-AF2D-84C07CE45B91

P356

Q36666967-D2681151-A3F8-4391-98A9-89E9BE4E6056

P433

Q36666967-2A931943-2DFB-4CA5-9863-EF6D20C3DAFC

P478

Q36666967-BADF1356-B84C-495D-BF3C-2AC2F9F49C6E

P577

Q36666967-491AA16B-7517-47EF-80C7-DD1283DEBA11

P698

Q36666967-29D2DB36-5AE7-45BB-BD24-A547F5D41005

P932

Q36666967-1AD01BDC-4F40-42AD-A011-2908CC8FE400

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Hemoglobin level variability: associations with mortality.

@en

P2093

Allan J Collins

http://www.w3.org/2001/XMLSchema#string

Brian D Bradbury

http://www.w3.org/2001/XMLSchema#string

David T Gilbertson

http://www.w3.org/2001/XMLSchema#string

Eric D Weinhandl

http://www.w3.org/2001/XMLSchema#string

James P Ebben

http://www.w3.org/2001/XMLSchema#string

Robert N Foley

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Hematocrit levels and hospitalization risks in hemodialysis patients.

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

Effect of variability in anemia management on hemoglobin outcomes in ESRD.

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

P304

133-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.01610407

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18045862

http://www.w3.org/2001/XMLSchema#string

P932

2390986

http://www.w3.org/2001/XMLSchema#string